Another important aspect is that inhibition of NF-κB might target cancer not only directly by blocking anti-apoptosis mechanisms of malignant cells, but also indirectly by shifting macrophages from the tumor-tolerating M2-polarization stage towards the tumor-attacking M1-stage [102]. The gene discussed is NFKB1; the disease is neoplasm.